ATE109792T1 - Bereicherung und konzentrierung von proteinen durch ultrafiltration. - Google Patents

Bereicherung und konzentrierung von proteinen durch ultrafiltration.

Info

Publication number
ATE109792T1
ATE109792T1 AT89118796T AT89118796T ATE109792T1 AT E109792 T1 ATE109792 T1 AT E109792T1 AT 89118796 T AT89118796 T AT 89118796T AT 89118796 T AT89118796 T AT 89118796T AT E109792 T1 ATE109792 T1 AT E109792T1
Authority
AT
Austria
Prior art keywords
ultrafiltration
enrichment
concentration
proteins
whey
Prior art date
Application number
AT89118796T
Other languages
English (en)
Inventor
Christopher Thurman Cordle
Ronald Lewis Thomas
Larry Grant Criswell
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE109792T1 publication Critical patent/ATE109792T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1425—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of whey, e.g. treatment of the UF permeate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Water Supply & Treatment (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT89118796T 1988-10-12 1989-10-10 Bereicherung und konzentrierung von proteinen durch ultrafiltration. ATE109792T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/256,813 US4897465A (en) 1988-10-12 1988-10-12 Enrichment and concentration of proteins by ultrafiltration

Publications (1)

Publication Number Publication Date
ATE109792T1 true ATE109792T1 (de) 1994-08-15

Family

ID=22973692

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89118796T ATE109792T1 (de) 1988-10-12 1989-10-10 Bereicherung und konzentrierung von proteinen durch ultrafiltration.

Country Status (13)

Country Link
US (1) US4897465A (de)
EP (1) EP0363896B1 (de)
JP (1) JPH02218691A (de)
KR (1) KR900005998A (de)
AT (1) ATE109792T1 (de)
AU (1) AU624633B2 (de)
CA (1) CA1330050C (de)
DE (1) DE68917407T2 (de)
ES (1) ES2061873T3 (de)
IE (1) IE64919B1 (de)
IL (1) IL91781A (de)
MX (1) MX163729B (de)
NZ (1) NZ230993A (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729031D0 (en) * 1987-12-11 1988-01-27 Express Foods Group Ltd Isolation of immunoglobulin rich fraction from whey
US5030720A (en) * 1988-09-01 1991-07-09 Merck & Co., Inc. Pres2+S hepatitis B vaccine derived from plasma
US5130237A (en) * 1989-06-19 1992-07-14 Clemson University Substrate conversion with an enzyme immobilized on an ultrafiltration membrane
DE4026365A1 (de) * 1990-08-21 1992-02-27 Biotest Pharma Gmbh Sterilfiltrierte kolostralmilch
US5270450A (en) * 1991-02-28 1993-12-14 Abbott Laboratories Soy protein isolates
IE914558A1 (en) * 1991-02-28 1992-09-09 Abbott Lab Isolation of proteins by ultrafiltration
CH687055A5 (de) * 1993-12-03 1996-09-13 Bucher Guyer Ag Masch Verfahren und Vorrichtung zum Eindicken von Fest/Fluessig-Gemischen mittels Membrantechnologie.
US5310877A (en) * 1993-04-08 1994-05-10 E. I. Du Pont De Nemours And Company Method for separating serum albumin and gamma globulin
US5344565A (en) * 1993-07-26 1994-09-06 Pall Corporation Method of treating a clogged porous medium
NL9301653A (nl) * 1993-09-24 1995-04-18 X Flow Bv Werkwijze voor het verwijderen van troebelheid veroorzakende bestanddelen uit een vloeistof met behulp van microfiltratie.
US5468844A (en) * 1994-01-07 1995-11-21 Protose Technologies Inc. Process for the membrane-filtering of protein solutions
US5707678A (en) * 1995-04-12 1998-01-13 Galagen Inc. Method for microfiltration of milk or colostral whey
US5654025A (en) * 1995-10-30 1997-08-05 Raghunath; Bala Ultrafiltration of cooled milk
US6268487B1 (en) 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
CA2197515A1 (en) * 1996-07-15 1998-01-16 Reyad Mahmoud Methods of treating milk products
CA2264630C (en) 1996-09-06 2006-12-12 Pall Corporation Shear separation method and system
WO1998054195A1 (en) 1997-05-30 1998-12-03 Bion, Inc. Large-scale isolation and purification of hif
TW409035B (en) 1997-06-04 2000-10-21 Gist Brocades Bv Starch-based enzyme granulates
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
EP1071744B1 (de) * 1998-04-14 2003-06-25 Dsm N.V. Membranfiltration
US6313273B1 (en) * 1999-08-25 2001-11-06 Abbott Laboratories Soy proteins and methods for their production
CA2408124A1 (en) * 2000-05-05 2001-11-15 Harry M. Meade Transgenically produced decorin
US20040219281A1 (en) * 2000-11-21 2004-11-04 Cargill, Incorporated Modified oilseed material
US7429399B2 (en) * 2001-06-18 2008-09-30 Solae, Llc Modified oilseed material
US6630195B1 (en) 2000-11-21 2003-10-07 Cargill, Incorporated Process for producing oilseed protein products
AU2001297915B2 (en) 2000-11-21 2006-06-15 Cargill, Inc Modified oilseed material
US6875459B2 (en) * 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
MY150740A (en) * 2002-10-24 2014-02-28 Abbvie Biotechnology Ltd Low dose methods for treating disorders in which tnf? activity is detrimental
WO2004050847A2 (en) * 2002-11-27 2004-06-17 Gtc Biotherapeutics, Inc. Modified antibodies stably produced in milk and methods of producing same
US7354616B2 (en) * 2003-11-25 2008-04-08 Solae, Llc Modified oilseed material with a high gel strength
US7282571B2 (en) * 2004-02-03 2007-10-16 Cytoskeleton Inc. Methods for stabilizing proteins
US20050220978A1 (en) * 2004-03-31 2005-10-06 Cargill, Incorporated Dispersible protein composition
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
US20080019905A9 (en) * 2005-02-18 2008-01-24 Strome Scott E Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
CN101484470B (zh) * 2005-10-21 2014-07-23 阿伊沃生物制剂有限公司 具有增强的抗体依赖性细胞毒性活性的抗体及其生产方法和用途
RU2476442C2 (ru) 2007-03-29 2013-02-27 Эббот Лэборетриз Кристаллические антитела против il-12 человека
US20110229460A1 (en) * 2008-05-01 2011-09-22 Gtc Biotherapeutics, Inc. anti-cd137 antibody as an agent in the treatment of inflammatory conditions
NZ606283A (en) * 2008-11-28 2014-08-29 Abbvie Inc Stable antibody compositions and methods for stabilizing same
EP2435474A2 (de) 2009-05-27 2012-04-04 Baxter International Inc Verfahren zur herstellung einer hochkonzentrierten immunglobulinzuberei­tung für die subkutane anwendung
US8993294B2 (en) 2009-08-10 2015-03-31 Danisco Us Inc. Cross-flow membrane filtration-based process for protein recovery
CA2872907A1 (en) 2012-05-09 2013-11-14 The University Of Akron Enzyme-based protein separation and enrichment from soy meal, wheat meal, and other protein-rich materials derived from plant seeds, fruits and other biomass
KR102163004B1 (ko) 2012-08-22 2020-10-07 크래프트 푸즈 그룹 브랜즈 엘엘씨 발효유 성분을 갖는 가공 치즈 및 제조 방법
EP3636657A1 (de) * 2018-10-08 2020-04-15 Ablynx N.V. Chromatographiefreies antikörperreinigungsverfahren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3431201A (en) * 1967-08-29 1969-03-04 Atomic Energy Commission Hyperfiltration process having ion exchange pretreatment
ES369944A1 (es) * 1969-07-26 1971-12-01 Inst Llorente S A Procedimiento para separar proteinas en estado de gran pu- reza a partir de mezclas complejas proteicas.
US3977967A (en) * 1973-05-10 1976-08-31 Union Carbide Corporation Ultrafiltration apparatus and process for the treatment of liquids
NL7603369A (en) * 1976-03-31 1977-10-04 Stichting Bedrijven Van Het Selective removal of inorganic ions from aq. protein concentrates - by ultrafiltration and diafiltration at controlled pH
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
DE3432718C1 (de) * 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
FR2605322B1 (fr) * 1986-10-20 1989-04-28 Applic Tech Nles Procede de separation de certaines proteines du lactoserum ou du lait.

Also Published As

Publication number Publication date
IE64919B1 (en) 1995-09-20
US4897465A (en) 1990-01-30
IE893057L (en) 1990-04-12
NZ230993A (en) 1991-11-26
ES2061873T3 (es) 1994-12-16
AU4257089A (en) 1990-04-26
CA1330050C (en) 1994-06-07
IL91781A (en) 1994-06-24
EP0363896B1 (de) 1994-08-10
MX163729B (es) 1992-06-17
IL91781A0 (en) 1990-06-10
DE68917407T2 (de) 1995-02-02
JPH02218691A (ja) 1990-08-31
AU624633B2 (en) 1992-06-18
KR900005998A (ko) 1990-05-07
DE68917407D1 (de) 1994-09-15
EP0363896A2 (de) 1990-04-18
EP0363896A3 (de) 1991-08-14

Similar Documents

Publication Publication Date Title
ATE109792T1 (de) Bereicherung und konzentrierung von proteinen durch ultrafiltration.
DK38892D0 (da) Proteinpraeparat, monoklonalt antistof fremstillet dermed, fremgangsmaade og middel til detektering, dna-sekvens og extrachromosomalt element indeholdende en saadan dna-sekvens
DE240975T1 (de) Menschliches gamma-interferon-spezifisches rezeptorprotein, antikoerper gegen dieses protein, verfahren zur herstellung dieses proteins und dieses antikoerpers und dieses protein und diesen antikoerper enthaltende zusammensetzungen.
FI854187A0 (fi) Immunoanalyser foer denaturerade proteinanalyser, saerskilt hb alc, samt antikroppar anvaendbara i dessa.
NZ224057A (en) A polypeptide of a vascular anticoagulant protein and method of preparation
GB8723651D0 (en) Process for containing concentrates
DK0383234T3 (da) Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling
DE3773963D1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
DE3877338T2 (de) Isolierung einer immunoglobulinreichen molke-fraktion.
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
EP0299741A3 (de) Verfahren und Vorrichtung zur Sequenzierung von Proteinen oder Peptiden
DE3854550T2 (de) HIV-Peptide und Methoden für den Nachweis von HIV.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
DE3273606D1 (en) Process for the purification or concentration of biologically active proteins, and appropriate means therefor
DE59310073D1 (de) Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen
ATE82471T1 (de) Verfahren zur abtrennung bestimmter proteine aus molke.
DE68917520T2 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
ATE90569T1 (de) Praeparat mit antikoerperaktivitaet und breitem wirkungsspektrum, daraus bestehende oder diese enthaltende mittel und deren verwendung zur behandlung von bakteriell oder toxin-bedingten erkrankungen und zur bekaempfung von protozoen.
DE3783425D1 (de) Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen.
DE3853315D1 (de) Verfahren zur quantitativen Bestimmung von Serumproteinen in Körperflüssigkeiten und Mittel zur Durchführung des Verfahrens.
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
DE3861648D1 (de) Modifizierte anorganische filtermembran zur proteintrennung.
DE3784891T2 (de) Verfahren zur Isolierung von säurestabilen, biologisch aktiven Proteinen.
SE8305667D0 (sv) Adenocarcinoma related new antigenic determinants and antibodies specific thereto, processes for their preparation and reagent systems pertaining to them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee